HUAPONT LIFE SCIENCES' subsidiary has obtained the drug registration certificate for Mometasone Furoate Cream

Zhitong
2025.09.16 09:24
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, HUAPONT LIFE SCIENCES announced that its wholly-owned subsidiary Chongqing Huabong Pharmaceutical Co., Ltd. (referred to as "Huabong Pharmaceutical") recently received two specifications of the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Mometasone Furoate Cream. Mometasone Furoate Cream is mainly used for eczema, neurodermatitis, atopic dermatitis, and pruritus

According to the Zhitong Finance APP, Huapont Life Sciences (002004.SZ) announced that its wholly-owned subsidiary Chongqing Huapont Pharmaceutical Co., Ltd. (referred to as "Huapont Pharmaceutical") recently received two specifications of the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Mometasone Furoate Cream. Mometasone Furoate Cream is mainly used for eczema, neurodermatitis, atopic dermatitis, and pruritus

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer